Tsumura & Co. · TSE:4540

Tsumura & — Investor Presentation (May 2016)

33 slides from Tsumura &'s investor presentation, May 13, 2016

  1. Slide 1: SESE AS a RR De

    2016 2021 2016 5 13 SESE AS a RR De

  2. Slide 2: *CEBS BANME fas

    *CEBS BANME fas BACRRENSITS RRR: HED SBECUNFELEISEN BARS CHARS OMAICKY HCHO? REORREAICRRMLET © 2021FEYaY: RMBSEV ay oREH “BA"OVLS — “N’OVYLI fei Cae “FO-INIb:s =v F” OTSUMURA oMPMACLHH “BB” OTIN-VaAvICKSMESMHAORE °MPGORE BHO S LHEHBL, SHOCVAYCALAAA BCRRe BT TAIIChO MR TSUMURA-DNA EZSvE TATE I ae

  3. Slide 3: Kampo Tsumura TU-100

    2021 KAMPO TSUMURA TU-100 3

  4. Slide 4: SESE AS a RR De

    2012 2015 SESE AS a RR De

  5. Slide 5: EPS ROE

    2012 2015 1. 2. 3. 2015 2012 2013 2014 2015 1,230 1,056 1,101 1,104 1,126 –104 295 231 225 195 198 –97 % 24.0 21.9 20.4 17.6 17.6 –6.4 190 153 180 140 125 –65 EPS 269 217 255 199 178 –91 ROE % 14.0 14.1 14.5 10.1 8.3 –5.7 129 1,180 995 1,027 1,052 1,075 –105 5 386 262 280 286 291 –95 5

  6. Slide 6: 2012 2015 2011 2013 2013

    2012 2015 1 2 2011 2013 3 2013 6

  7. Slide 7: 2012 2015 2015 34.7% 40.0% 5.3pt +3.5pt +1.6pt +0.2pt +5.3pt 7

    2012 2015 2015 34.7% 40.0% 5.3pt +3.5pt +1.6pt +0.2pt +5.3pt 7

  8. Slide 8: TU-100

    2012 2015 3 TU-100 • • • ROE14 • • • TU-100 Phase 8

  9. Slide 9: SESE AS a RR De

    2016 2021 SESE AS a RR De

  10. Slide 10: 2016 2021

    2016 2021 21 10

  11. Slide 11: 2016 2021

    2016 2021 11

  12. Slide 12: EPS ROE targets

    2016 2021 2018 2021 1,200 1,350 140 190 2016 2017 2018 11.5% 14% 2020 100 130 115 EPS 140 185 ROE 6% 8% 2018 2021 3 2019 12

  13. Slide 13: Kampo

    2016 2021 KAMPO TSUMURA 13

  14. Slide 14: , ry r % ID» kK Th ea v* we f bel m4 ae

    2016 2021 1 3 , ry r % ID» kK Th ea v* we f bel m4 5 ae iN A ve n4 Vg eC hey | hee

  15. Slide 15: 1

    1

  16. Slide 16: HP GP

    2016 2021 HP GP MR 1. 3 2. 3. 16

  17. Slide 17: Growing

    2016 2021 Growing *1 Growing *2 3 BPSD ( ) 2021 100 3 *1 *2 5 17

  18. Slide 18: EBM ADME

    2016 2021 Growing EBM ADME RCT (ADME) 23 1 12 16 GERD 14 5 18

  19. Slide 19: SBI

    2016 2021 IT SBI 19

  20. Slide 20: 2016 2021

    2016 2021 10 20

  21. Slide 21: FDA HPLC-FP CGMP

    2016 2021 TU-100 1 2012 2013 2014 2015 2016 2017 2018 FDA HPLC-FP CGMP IBS IBS IBS POI 2016 P P POI 2017 2018 P P 2011 2014 P *1 ADME*2 *1 FDA *2 FDA IBS POI 21

  22. Slide 22: 2

    2

  23. Slide 23: CF CF

    2016 2021 CF CF 23

  24. Slide 24: CF 43% 36% 36% 38% 2015 2016 2017 2018 2021 50%

    2016 2021 CF 43% 36% 36% 38% 2015 2016 2017 2018 2021 50% 24

  25. Slide 25: PIC/S GMP

    2016 2021 CF 1 • PIC/S GMP • • 2021 2015 30 2016 2018 100 2019 2021 80 25

  26. Slide 26: SCM

    2016 2021 CF SCM > > 26

  27. Slide 27: CF 2016 2021 2021 40%

    2016 2021 CF 2016 2021 6 450 1 2021 40% 27

  28. Slide 28: 3

    3

  29. Slide 29: 1. 3. > > 100% > > 2. 4. > > > > >

    2016 2021 1. 3. > > 100% > > 2. 4. > > > > > 100% > > 2016 > > 29

  30. Slide 30: ESG

    2016 2021 ESG ESG • • 100% • • 1 • • • • • • IR 30

  31. Slide 31: ROE

    2016 2021 2016 2021 6 • 550 • 60 880 • 270 • 960 2016 2021 6 • 170 • 42 • 40 • • • • • 2021 ROE 8% 31

  32. Slide 32: 2006 2006 2007 008 2009 2010 2011 2012 2013 2014 2015 2018 2021 2011

    2006 100 241 234 230 217 190 156 117 110 110 100 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2018 2021 2011 2015 2013 32

  33. Slide 33: TEL 03-6361-7101

    TEL 03-6361-7101 • • •

Tsumura & — Investor Presentation (May 2016) on 6ix